 |
Research Interests:
- Epidermal growth factor receptor signaling and cell motility.
- EGFR-mediated motility signaling in fibroblasts is negatively affected by inhibitory signals during wound repair and by aging.
- Anti-inflammatory chemokine IP-10 inhibits motility but not proliferation, and this occurs downstream of PLC? and MAP kinase signaling. EGFR-mediated activation of calpain and subsequent cell-substratum de-adhesion is inhibited by IP-10 signaling through cAMP-PKA signaling pathway.
- During aging, both motility and mitogenesis are decreased, with the EGF response being lost in near senescent dermal fibroblasts. This is a consequence of reduced levels of EGFR due to markedly reduced transcription, expression of 'young' levels of EGFR restores the EGF responsiveness.
|
|
Publications:
- Shiraha H., Koide N., Hada H., Ujike K., Nakamura M., Shinji T., Gotoh S., Tsuji T. Improvement of serum amino acid profile in hepatic failure with the bio-artificial liver using multicellular hepatocyte spheroids. Biotechnologies and Bioengineering 50; 416-421, 1996
- Shiraha H., Glading A., Gupta K., Wells A. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. Journal of Cell Biology 146(1); 243-253, 1999
- Shiraha H., Drabik K., Gupta K., and Wells A. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. Journal of Biological Chemistry. 275(25); 19343-19351, 2000
|